Details

Autor(en) / Beteiligte

• Carlson, Robert W
• Allred, D Craig
• Anderson, Benjamin O
• Burstein, Harold J
• Edge, Stephen B
• Farrar, William B
• Forero, Andres
• Giordano, Sharon Hermes
• Goldstein, Lori J
• Gradishar, William J
• Hayes, Daniel F
• Hudis, Clifford A
• Isakoff, Steven Jay
• Ljung, Britt-Marie E
• Mankoff, David A
• Marcom, P Kelly
• Mayer, Ingrid A
• McCormick, Beryl
• Pierce, Lori J
• Reed, Elizabeth C
• Smith, Mary Lou
• Soliman, Hatem
• Somlo, George
• Theriault, Richard L
• Ward, John H
• Wolff, Antonio C
• Zellars, Richard
• Kumar, Rashmi
• Shead, Dorothy A

Titel

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines

Ist Teil von

• Journal of the National Comprehensive Cancer Network, 2012-07, Vol.10 (7), p.821-829

Ort / Verlag

United States

Erscheinungsjahr

2012

Quelle

MEDLINE

Beschreibungen/Notizen

• These NCCN Guidelines Insights highlight the important updates/changes specific to the management of metastatic breast cancer in the 2012 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer. These changes/updates include the issue of retesting of biomarkers (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2) on recurrent disease, new information regarding first-line combination endocrine therapy for metastatic disease, a new section on monitoring of patients with metastatic disease, and new information on endocrine therapy combined with an mTOR inhibitor as a subsequent therapeutic option.